The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Peptide Reconstitution Guide Peptide Injection Sites Guide Peptide Storage Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Vendor Scoreboard All Vendor Comparisons Peptide Price Comparison Vendor Closures & Status How to Read a Peptide COA How to Vet a Peptide Vendor Why Purgo Labs Purgo Labs Review Purgo Labs Discount Code Where to Buy by Compound Legal Status Shop Purgo Labs

BPC-157 vs Thymosin Alpha-1

BPC-157 vs Thymosin Alpha-1: tissue repair peptide vs immune modulator. BPC-157 focuses on healing and gut protection; Thymosin Alpha-1 (Tα1) modulates T-cell function and innate immunity.

Mechanism Comparison

BPC-157: upregulates growth factors at injury sites, promotes angiogenesis, modulates nitric oxide synthesis, gut protective. Thymosin Alpha-1: thymic peptide that promotes T-cell maturation, NK cell activity, and dendritic cell function.

Research Applications

BPC-157: tissue repair, gut healing, tendon/ligament recovery, neurological research. Thymosin Alpha-1: immune deficiency research, viral infection models, cancer immunotherapy adjunct research.

Combination Protocol

These compounds target different systems and can be combined. BPC-157: 250–500 mcg/day subcutaneously. Thymosin Alpha-1: 1.6 mg subcutaneously 2x/week (standard clinical dose).